Coronary bypass surgery patients who received a radial artery as their second bypass conduit had significantly better 10-year survival than did patients who received a saphenous vein graft in a ...

The saphenous-vein graft is the most common conduit for coronary-artery bypass grafting (CABG). The influence of the vein-graft harvesting technique on long-term clinical outcomes has not been well ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...

Madrid, Spain – 1 September 2025: After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. CHICAGO — In patients with chronic limb-threatening ...

The use of dual antiplatelet therapy (DAPT), either with clopidogrel or ticagrelor (Brilinta; AstraZeneca), appears to reduce the risk of failing saphenous vein grafts among patients who undergo CABG ...

Figure 1. A 75-year-old man who was taking 8 mg of prednisone per day for systemic lupus erythematosus was admitted for the evaluation of an enlarging chest mass. Seventeen years earlier he had ...

Chicago, IL - Results of a new randomized trial have shown noninferiority for a new filter distal protection system compared with the currently approved balloon occlusion and aspiration system in ...

A 53-year-old German man became the first person to undergo a new, non-surgical technique that turned one of his coronary veins into a coronary artery to bypass a blockage, according to a special ...